# Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products, Division 5

Extent: E+W+S+N.I.

Whenever a product forms part of a vaccination scheme recommended by the applicant, the priming or booster effect or the contribution of the veterinary immunological product to the efficacy of the scheme as a whole shall be demonstrated.

---
Source: https://www.legislation.gov.uk/eudr/2001/82/annex/I/title/II/part/4/chapter/II/division/A/division/5 (the official version)
Page: https://openlegislation.uk/eu-directive-2001-82/annex-I/title-II/part-4/chapter-II/division-A/division-5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

